Glenmark Pharmaceuticals
GLENMARK.NS
#2590
Rank
C$7.75 B
Marketcap
$27.49
Share price
0.55%
Change (1 day)
111.34%
Change (1 year)

P/S ratio for Glenmark Pharmaceuticals (GLENMARK.NS)

P/S ratio as of November 2024 (TTM): 3.92

According to Glenmark Pharmaceuticals 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 5.93. At the end of 2024 the company had a P/S ratio of 2.93.

P/S ratio history for Glenmark Pharmaceuticals from 2012 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20242.9345.69%
20232.01104.46%
20220.9830-20.26%
20211.23-6.98%
20201.3340.45%
20190.9437-53.87%
20182.0510.39%
20171.85-34.6%
20162.83-21.58%
20153.6115.69%
20143.1226.2%
20132.48-15.9%
20122.94